{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:45:27Z","timestamp":1791254727990,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.cell.2022.01.028","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T10:52:55Z","timestamp":1646304775000},"page":"750-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The RTS,S vaccine\u2014a chance to regain the upper hand against malaria?"],"prefix":"10.1016","volume":"185","author":[{"given":"Photini","family":"Sinnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2022.01.028_bib1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2022.01.028_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2022.01.028_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.6.1.9677","article-title":"From the circumsporozoite protein to the RTS, S\/AS candidate vaccine","volume":"6","author":"Cohen","year":"2010","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.cell.2022.01.028_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.6204383","article-title":"Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum","volume":"225","author":"Dame","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.cell.2022.01.028_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1073\/pnas.85.4.1199","article-title":"Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule","volume":"85","author":"Good","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2022.01.028_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1126\/science.2020852","article-title":"Progress toward malaria preerythrocytic vaccines","volume":"252","author":"Hoffman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cell.2022.01.028_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.10.062","article-title":"Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case","author":"Kochhar","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2022.01.028_bib8","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2022.01.028_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1098\/rstb.1984.0113","article-title":"Development of sporozoite vaccines","volume":"307","author":"Nussenzweig","year":"1984","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.cell.2022.01.028_bib10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/milmed\/134.9.1176","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity","volume":"134","author":"Nussenzweig","year":"1969","journal-title":"Mil. Med."},{"key":"10.1016\/j.cell.2022.01.028_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with\u00a0or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2022.01.028_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group","volume":"336","author":"Stoute","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2022.01.028_bib13","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.171.12.6961","article-title":"Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T\u00a0cells producing IFN-gamma","volume":"171","author":"Sun","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2022.01.028_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.6985745","article-title":"Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite","volume":"207","author":"Yoshida","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.cell.2022.01.028_bib15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0923-2494(91)90144-8","article-title":"The multifactorial character of the protective immunity induced by immunization with sporozoites","volume":"142","author":"Zavala","year":"1991","journal-title":"Res. Immunol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867422001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867422001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:59:26Z","timestamp":1758801566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867422001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0092867422001398"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2022.01.028","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The RTS,S vaccine\u2014a chance to regain the upper hand against malaria?","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2022.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}